| Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181) |
|---|
| 03/13/2003 | US20030049725 Anti-TNF antibodies, compositions, methods and uses |
| 03/13/2003 | CA2459348A1 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 03/13/2003 | CA2458399A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments |
| 03/12/2003 | CN1402730A Thiazolo (4,5-D) pyrimidine compounds |
| 03/12/2003 | CN1402702A Beta 2-adrenergic receptor agonists |
| 03/06/2003 | WO2003018582A1 Novel imidazopyridine compounds with therapeutic effect |
| 03/06/2003 | WO2003018031A2 Single dose azithromycin for treating respiratory infections |
| 03/06/2003 | US20030045518 Certain bis(thio-hydrazide amide) compounds significantly enhance the anticancer activity of taxol. |
| 03/06/2003 | US20030045479 Novel N-formyl hydroxylamine compounds, compositions and methods of use |
| 03/06/2003 | CA2458135A1 Single dose azithromycin for treating respiratory infections |
| 03/06/2003 | CA2456350A1 Novel imidazopyridine compounds with therapeutic effect |
| 03/05/2003 | EP1286975A1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists |
| 03/05/2003 | EP1286672A2 S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders |
| 03/04/2003 | US6528486 Peptide agonists of GLP-1 activity |
| 02/27/2003 | WO2003016302A1 Diamine derivatives |
| 02/27/2003 | WO2003015812A2 Beta-amyloid-analogue-t-cell epitop vaccine |
| 02/27/2003 | CA2456841A1 Cyclohexyl and piperidine diamine derivatives useful as activated blood coagulation factor x inhibitors |
| 02/26/2003 | CN1399639A New oxabispidine compound useful in treatment of cardiac arrhythmias |
| 02/25/2003 | US6525060 Triazolo(4,5-d)pyrimidine compounds |
| 02/22/2003 | CA2355573A1 Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts |
| 02/20/2003 | WO2002065979A3 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
| 02/20/2003 | US20030036543 Especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease. |
| 02/20/2003 | US20030036504 Modululation of both fasting and postprandial lipid levels. |
| 02/20/2003 | US20030035853 Antiinflammatory agents, analgesics; fatty acid mixture and plant extracts |
| 02/19/2003 | EP1283828A1 Novel polymorph v of torasemide |
| 02/18/2003 | US6521632 Method for the treatment or prevention of a disease mediated by the alpha-2B-adrenoceptor |
| 02/18/2003 | US6521270 Compositions comprising nitrofurantoin and uva ursi |
| 02/18/2003 | US6521253 Low molecular weight peptide thrombin inhibitor having pH dependent solubility and a combination of microcrystalline cellulose and sodium starch glycollate |
| 02/18/2003 | CA2351004C Formulation |
| 02/12/2003 | CN1396827A Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives |
| 02/11/2003 | US6518428 The present invention relates to the area of platinum drugs. In particular, it relates to an improved process for preparing platinum complexes having the general formula (Ia) or (Ib): as defined of herein, |
| 02/06/2003 | WO2003010159A1 Piperidine derivatives as nmda receptor antagonists |
| 02/06/2003 | WO2002059112A3 Pyrazole compounds useful as protein kinase inhibitors |
| 02/05/2003 | EP1003486B1 Pharmaceutical compositions containing an effervescent acid-base couple |
| 01/30/2003 | WO2003008407A2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 01/30/2003 | WO2003007912A2 Lyophilized formulation comprising olanzapine |
| 01/30/2003 | US20030022885 Pyrazole compounds useful as protein kinase inhibitors |
| 01/30/2003 | CA2450437A1 1-phenylsulphonyl-1,3-dihydro-2h-indol-2-one derivatives, their preparation and their therapeutic application |
| 01/30/2003 | CA2448724A1 2-methyl-thieno-benzodiazepine lyophilized formulation |
| 01/29/2003 | EP1278747A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 01/29/2003 | CN1394141A Fulvestrant formulation |
| 01/23/2003 | WO2003006430A1 Taxol enhancer compounds |
| 01/23/2003 | WO2003006428A1 Taxol enhancer compounds |
| 01/23/2003 | WO2002050066A3 Pyrazole compounds useful as protein kinase inhibitors |
| 01/22/2003 | CN1391880A Electric moxibustion instrument |
| 01/21/2003 | US6509365 Useful as inhibitors of poly(ADP-ribose)polymerase and for the production of drugs. |
| 01/21/2003 | US6509351 A method of inhibiting TNF- alpha in a patient in need thereof which comprises administering to said patient an effective amount of a compound for inflamation |
| 01/16/2003 | WO2003004487A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 01/16/2003 | CA2452597A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 01/15/2003 | CN1391575A Nitrogen containing heterobicycles as factor XA inhibitors |
| 01/15/2003 | CN1391570A Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 01/15/2003 | CN1391562A Quinazoline derivatives as pharmaceuticals |
| 01/15/2003 | CN1391561A Quinazoline compounds and pharmaceutical compositions containing them |
| 01/15/2003 | CN1391481A 疫苗 Vaccine |
| 01/15/2003 | CN1391469A Npyy5拮抗剂 Npyy5 antagonist |
| 01/14/2003 | US6506750 Morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
| 01/09/2003 | WO2003002531A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/09/2003 | WO2002059111A3 Pyrazole compounds useful as protein kinase inhibitors |
| 01/09/2003 | CA2450722A1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/08/2003 | EP1273581A1 New process for the preparation of the trihydrate of the magnesium salt of S-omeprazole |
| 01/08/2003 | EP1272468A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 01/08/2003 | EP1272200A1 Divided dose therapies with vascular damaging activity |
| 01/08/2003 | EP1272199A1 Combination therapies with vascular damaging activity |
| 01/08/2003 | EP0906107B1 Compositions comprising vx 478 and a water soluble vitamin e compound such as vitamin e-tpgs |
| 01/08/2003 | CN1390216A Polymorphsof crystalline (2-benzhycrryl-1-azabicyclo [2,2,2] oct-3-YC)-(5-isopropyl-2-methoxybenzyl)-ammoniumchloride as NK-1 receptor antagonists |
| 01/08/2003 | CN1390201A Cyclic amine compounds as CCR5-antagonists |
| 01/08/2003 | CN1390191A Hydroxyeicosatetraenoic acid analogs and methods of their use in treating dry eye disorders |
| 01/07/2003 | US6504035 3-deoxy-desmycosin derivatives and process for their preparation |
| 01/03/2003 | WO2003000688A1 Azaindoles |
| 01/03/2003 | WO2003000680A1 Diamine derivatives |
| 01/03/2003 | WO2003000657A1 Diamine derivatives |
| 01/03/2003 | WO2003000293A1 Pharmaceutical formulation |
| 01/03/2003 | WO2003000263A1 Rapid onset formulation |
| 01/03/2003 | WO2002066056A3 Synthetic vaccines comprising polyhydroxypolymer carriers |
| 01/03/2003 | CA2450449A1 Pharmaceutical formulation |
| 01/02/2003 | US20030004214 Irritable bowel disease |
| 01/02/2003 | US20030004167 Imidazo-heterobicycles as factor Xa inhibitors |
| 01/02/2003 | US20030004164 Anticancer agents; autoimmune diseases |
| 01/02/2003 | US20030004161 Anticancer agents; autoimmune diseases |
| 01/02/2003 | EP1268470A1 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof |
| 01/02/2003 | EP1268469A1 N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants |
| 01/02/2003 | EP1268468A1 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs |
| 01/01/2003 | CN1388759A Medicine containing Anemonin as effective component for treating aseptic inflammation |
| 01/01/2003 | CN1097463C Method for preparing medicinal moxibustion materials extractive preparation for electrical moxibustion therapy |
| 12/27/2002 | WO2002102790A1 N-formyl hydroxylamine compounds as inhibitors of pdf |
| 12/27/2002 | WO2002069989A3 Aquatic animal treatment method and composition containing pimenta extract |
| 12/27/2002 | CA2448526A1 N-formyl hydroxylamine compounds as inhibitors of pdf |
| 12/26/2002 | US20020198257 Halogenated 2-phenyl-1,2-ethanediol monocarbamate derivatives |
| 12/26/2002 | US20020198239 Oxidizing 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl)thio)-1H -benzimidazole into S-omeprazole in an organic solvent, convering formed S-omeprazole into corresponding potassium salt by treating with potassium source |
| 12/26/2002 | US20020198198 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 12/26/2002 | US20020198146 Method for the synthesis of peptide salts, their use and the pharmaceutical preparations, containing peptide salts |
| 12/25/2002 | CN1387531A Pyrazolo [4,3-d] pyrimidine derivs. |
| 12/25/2002 | CN1387527A Qinazoline derivs. as VEGF inhibitors |
| 12/25/2002 | CN1096853C Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof |
| 12/19/2002 | WO2002100413A1 A PHARMACEUTICAL COMBINATION COMPRISING EITHER (S)-2-ETHOXY-3- [4-(2-{4-METHANE SULFONYL OXYPHENYL} ETHOXY) PHENYL] PROPANOIC ACID OR 3-{4-[2-(4-TERT- BUTOXY CARBONYL AMINOPHENYL) ETHOXY] PHENYL} -(s)-2-ETHOXY PROPANOIC ACID AND A SULONYLUREA |
| 12/19/2002 | WO2002100402A1 Compositions comprising nitrofurantoin and uva ursi |
| 12/19/2002 | US20020193612 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes |
| 12/19/2002 | US20020193589 Mercaptoacetylamide derivatives, a process for their preparation and their use |
| 12/19/2002 | US20020192305 Inflammatory mediation obtained from atractylodes lancea |
| 12/19/2002 | CA2449944A1 Compositions comprising nitrofurantoin and uva ursi |